Frequently Asked Questions
What is the IgM & IgG Test?
The IgM & IgG Covid-19 Rapid Test is a rapid point-of-care test that detects both early & late marker antibodies in human finger-pricck (capillary) or venous whole blood, serum, and plasma samples.
What is the difference between the IgM & IgG Test & PCR Test?
There is a critical global need for serology test to complement the nucleic acid (PCR) test to diagnose COVID-19 infection. PCR tests are more effective in identifying infection during the brief-window of acute infection, but quickly become negative afterwards. Serology tests are able to detect COVID-19 for a prolonged period of time after disease resolution, which enables identification of prior infection, which is epidemiologically important to tracking and containing this pandemic.
How long will it take to get the test result?
The COVID-19 Rapid Test will provide test results in about 10-15 minutes. However, it is very important that the test is read within 30 minutes otherwise it will be an unreadable result.
Is the Rapid Testing Kit for COVID-19 FDA Approved?
The U.S. Food and Drug Administration is providing needed flexibility to labs & manufacturers so they may quickly produce tools needed for the pandemic. Traditional long waits and roadblocks to approval have been lifted to ensure that tests are able to be produced quickly, and are accurate & effective. As a result the testing kit is deemed to be accurate, effective, and safe and is FDA Emergency Approved. Moreover, as in previous emergencies, the FDA has been extremely proactive and supportive of test development by all comers- laboratories, and large and small commercial manufacturers- offering their expertise and support to speed development and to quickly authorize tests that the science supports.